search
Back to results

The Effect Of Medical Nutritional Therapy On Patients With Sarcopenic Obesity Requesting Peritone Dialysis Treatment

Primary Purpose

Peritoneal Dialysis Complication, Sarcopenic Obesity

Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
medical nutrition therapy in kidney diseases
Sponsored by
Atlas University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Peritoneal Dialysis Complication

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Volunteering to participate in research Be between the ages of 18-70 To receive peritoneal dialysis treatment and to come to the hospital regularly once a month for treatment Exclusion Criteria: Presence of any other disease that causes muscle wasting Patients using any supplement or enteral product in their diet

Sites / Locations

  • Marmara University

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Dietary and Behavioral Change Group

Arm Description

The experimental group will be required to adhere to a diet consisting of a 10-15% reduction in carbohydrate and a 1.2-1.4 g/kg body weight/day intake of protein. The participants will receive 4 times face-to-face meetings (on the first day and on week 1,5 and 9). Each face-to-face interview will last approximately 30 minutes. During the interview researcher will help the participants to determine their nutritional behaviors, plan and implement the diet.

Outcomes

Primary Outcome Measures

Change in muscle strength
Handgrip strength (kg) will be measured by using the CAMRY EH101 dynamometer. Hand grip strength <16 kg for women and <27 kg for men indicates low muscle strength.
Change in the skeletal muscle mass
Skeletal muscle mass (kg) will be measured by using bioelectrical impedance analysis.
Change in the physical performance
4-meter walking speed test will be performed. A walking speed of ≤0.8 m/sec is considered as an indicator of severe sarcopenia.
Change of the fat mass
Fat mass (kg) will be measured by using bioelectrical impedance analysis.
Changes of percentage of body fat
Percentage of body fat will be measured by using bioelectrical impedance analysis.
Changes of body mass index
The weight and height will be combined to report BMI in kg/m2.

Secondary Outcome Measures

Full Information

First Posted
February 24, 2023
Last Updated
June 26, 2023
Sponsor
Atlas University
search

1. Study Identification

Unique Protocol Identification Number
NCT05797181
Brief Title
The Effect Of Medical Nutritional Therapy On Patients With Sarcopenic Obesity Requesting Peritone Dialysis Treatment
Official Title
The Effect of Medical Nutrition Therapy on Anthropometric Measurements and Blood Parameters in Sarcopenic Obesity Patients Undergoing Peritoneal Dialysis Treatment
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
February 7, 2023 (Actual)
Primary Completion Date
May 8, 2023 (Actual)
Study Completion Date
May 15, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Atlas University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In this study, it was aimed to evaluate the effectiveness of medical nutrition therapy to be applied to patients with sarcopenic obesity receiving peritoneal dialysis treatment by measuring anthropometric measurements and blood parameters.
Detailed Description
Efficacy of medical nutrition therapy in patients with saecopenic obesity receiving peritoneal dialysis treatment, general information form after patients filled in the voluntary consent form, SARC-F questionnaire as sarcopenia screening test, International Physical Activity Questionnaire (IPAQ), muscle mass, muscle strength, physical performance, BIA measurement, anthropometric measurements, laboratory findings and three-day food consumption records will be evaluated.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Peritoneal Dialysis Complication, Sarcopenic Obesity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dietary and Behavioral Change Group
Arm Type
Experimental
Arm Description
The experimental group will be required to adhere to a diet consisting of a 10-15% reduction in carbohydrate and a 1.2-1.4 g/kg body weight/day intake of protein. The participants will receive 4 times face-to-face meetings (on the first day and on week 1,5 and 9). Each face-to-face interview will last approximately 30 minutes. During the interview researcher will help the participants to determine their nutritional behaviors, plan and implement the diet.
Intervention Type
Other
Intervention Name(s)
medical nutrition therapy in kidney diseases
Intervention Description
Planning and implementation of diets containing high protein, low potassium, low phosphorus, personalized adjusted carbohydrates
Primary Outcome Measure Information:
Title
Change in muscle strength
Description
Handgrip strength (kg) will be measured by using the CAMRY EH101 dynamometer. Hand grip strength <16 kg for women and <27 kg for men indicates low muscle strength.
Time Frame
Baseline to 3 months after diet programme
Title
Change in the skeletal muscle mass
Description
Skeletal muscle mass (kg) will be measured by using bioelectrical impedance analysis.
Time Frame
Baseline to 3 months after diet programme
Title
Change in the physical performance
Description
4-meter walking speed test will be performed. A walking speed of ≤0.8 m/sec is considered as an indicator of severe sarcopenia.
Time Frame
Baseline to 3 months after diet programme
Title
Change of the fat mass
Description
Fat mass (kg) will be measured by using bioelectrical impedance analysis.
Time Frame
Baseline to 3 months after diet programme
Title
Changes of percentage of body fat
Description
Percentage of body fat will be measured by using bioelectrical impedance analysis.
Time Frame
Baseline to 3 months after diet programme
Title
Changes of body mass index
Description
The weight and height will be combined to report BMI in kg/m2.
Time Frame
Baseline to 3 months after diet programme

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Volunteering to participate in research Be between the ages of 18-70 To receive peritoneal dialysis treatment and to come to the hospital regularly once a month for treatment Exclusion Criteria: Presence of any other disease that causes muscle wasting Patients using any supplement or enteral product in their diet
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ayşe Betül Demirbaş
Organizational Affiliation
Atlas University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Marmara University
City
Istanbul
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

The Effect Of Medical Nutritional Therapy On Patients With Sarcopenic Obesity Requesting Peritone Dialysis Treatment

We'll reach out to this number within 24 hrs